GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » Other Income (Expense)

CMG Pharmaceutical Co (XKRX:058820) Other Income (Expense) : ₩644 Mil (TTM As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is CMG Pharmaceutical Co Other Income (Expense)?

CMG Pharmaceutical Co's other income expense for the CMG Pharmaceutical Co's pretax income for the three months ended in Mar. 2024 was ₩1,699 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩644 Mil.

CMG Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for CMG Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMG Pharmaceutical Co Other Income (Expense) Chart

CMG Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.75 -2,071.51 124.64 -6,184.37 21.24

CMG Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,075.27 556.50 910.39 -2,520.92 1,698.52

CMG Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩644 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CMG Pharmaceutical Co  (XKRX:058820) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

CMG Pharmaceutical Co (XKRX:058820) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:005500 XKRX:102940 XKRX:092040 XKRX:000020 XKRX:008490 XKRX:102460 XKRX:003220 XKRX:084110 XKRX:007570 XKRX:001630 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Cheongdam-dong 18-20, No. B01, Gangnam-gu, Seoul, KOR, 135-949
Website
http://www.cmgpharma.co.kr
CMG Pharmaceutical Co Ltd is the sole pharmaceutical company and an affiliate company of CHA Health Systems. CHA Health Systems are integrated systems which include medical school, pharmacy school, research institutes, general hospitals and many affiliates which are related to stem cell research, biotechnology and pharmaceutical business all over the world.

CMG Pharmaceutical Co (XKRX:058820) Headlines

No Headlines